Alpha Tau Medical Ltd. (DRTSW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.4x

Market Cap

$349.50M

MomentumView details →

1D Return

+6.45%

YTD Return

+1120.59%

RSI (14)

58.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.4x

Market Cap

$349.50M

RSI (14)

58.8

MomentumView details →

1D Return

+6.45%

YTD Return

+1120.59%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−210.13%

ROA (TTM)

−68.96%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−17.78%

EBITDA YoY

−53.79%

EarningsView details →

EPS (Actual)

−$0.50

EPS Surprise

−254.91%

Beats (12Q)

1/12

Next Q EPS Est

−$0.14

Avg Surprise (4Q)

−95.08%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.34x

Current Ratio

11.09x

Quick Ratio

11.09x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−92.57M

Op. CF (TTM)

−26.68M

Next earningsNov 24, 2026 →

Latest newsMore news →

No recent news for DRTSW.

Similar companies

Lyell Immunopharma, Inc.LYEL Inhibikase Therapeutics, Inc.IKT Abeona Therapeutics Inc.ABEO Q32 Bio Inc.QTTB Sirnaomics Ltd.02257.HK Uni-Bio Science Group Limited00690.HK Find similar companies →

Latest newsMore news →

No recent news for DRTSW.